Explore more publications!

US Trial to Begin Over Social Media Firms Addicting Children

(MENAFN) Opening arguments are set to start Monday in a US trial accusing social media companies of designing products to foster addiction among children, with Meta CEO Mark Zuckerberg and YouTube chief Neal Mohan expected to testify.

The trial, which was postponed from late January due to a defense attorney’s illness, features a jury of six women and six men, and could extend into March. Instagram head Adam Mosseri is expected to testify during the first week, followed by Zuckerberg, who may appear in Los Angeles as early as next week.

The personal injury lawsuit, filed by the Social Media Victims Law Center, involves a 20-year-old California woman who claims that over a decade of social media use led to anxiety, depression, and body dysmorphia.

Meta’s legal team plans to dispute links between social media and teen mental health problems while emphasizing positive impacts. In a January blog post, the company stated that blaming social media companies alone for teen mental health issues “oversimplifies a serious issue,” calling the claims in the lawsuit inaccurate.

The case comes amid growing global scrutiny, with multiple countries implementing restrictions on social media use by minors. Many studies have suggested connections between social media use and mental health challenges among young people.

MENAFN10022026000045017281ID1110720508


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions